Who makes Desloratadine Fourfold Dose?

Desloratadine Fourfold Dose is developed by Universitaire Ziekenhuizen KU Leuven.

What development phase is Desloratadine Fourfold Dose in?

Desloratadine Fourfold Dose is in Phase 1.

Last reviewed 2026-04-20 · How we verify

Desloratadine Fourfold Dose

Universitaire Ziekenhuizen KU Leuven · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Desloratadine Fourfold Dose
Sponsor	Universitaire Ziekenhuizen KU Leuven
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Desloratadine Fourfold Dose CI brief — competitive landscape report
Desloratadine Fourfold Dose updates RSS · CI watch RSS
Universitaire Ziekenhuizen KU Leuven portfolio CI